Literature DB >> 11949935

Myophosphorylase deficiency (glycogenosis type V; McArdle disease).

S Dimaur1, A L Andreu, C Bruno, G M Hadjigeorgiou.   

Abstract

McArdle disease, one of the most common metabolic causes of exercise intolerance and recurrent myoglobinuria, is due to biochemical defects of the muscle isoform of glycogen phosphorylase. The gene for myophosphorylase (PGYM) is on chromosome 11, and 33 distinct mutations have been identified in patients from all over the world. In Caucasians, a nonsense mutation in exon 1 (R49X) is common enough to warrant screening of genomic DNA from blood before considering muscle biopsy. Other mutations are prevalent in different ethnic groups or are "private". Mutations are spread throughout the gene and there is no clear genotype:phenotype correlation. High-protein diet and aerobic exercise are beneficial, and gene therapy appears promising.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949935     DOI: 10.2174/1566524024605770

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  18 in total

1.  Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.

Authors:  Astrid Brull; Noemí de Luna; Albert Blanco-Grau; Alejandro Lucia; Miguel Angel Martin; Joaquin Arenas; Ramon Martí; Antoni L Andreu; Tomàs Pinós
Journal:  J Physiol       Date:  2015-05-18       Impact factor: 5.182

Review 2.  Molecular genetics of McArdle's disease.

Authors:  G Nogales-Gadea; J Arenas; A L Andreu
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

3.  Clinical Presentation and Management of Severe Acute Renal Failure in McArdle Disease.

Authors:  Majdi Hamadeh; Khalil Nasrallah; Zeinab Ajami; Rahil Zeaiter; Layan Abbas; Samih Hamadeh; Jawad Fares
Journal:  Clin Med Res       Date:  2021-05-13

4.  Don't you forget about me: considering acute rhabdomyolysis in ED patients with cocaine ingestion.

Authors:  Leah Nemiroff; Sasha Cormier; Constance LeBlanc; Nancy Murphy
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

5.  Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.

Authors:  M Deschauer; A Morgenroth; P R Joshi; D Gläser; P F Chinnery; J Aasly; H Schreiber; M Knape; S Zierz; M Vorgerd
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

6.  Inactivation of rabbit muscle glycogen phosphorylase b by peroxynitrite revisited: does the nitration of Tyr613 in the allosteric inhibition site control enzymatic function?

Authors:  Victor S Sharov; Nadezhda A Galeva; Elena S Dremina; Todd D Williams; Christian Schöneich
Journal:  Arch Biochem Biophys       Date:  2008-12-27       Impact factor: 4.013

Review 7.  McArdle disease: molecular genetic update.

Authors:  A L Andreu; G Nogales-Gadea; D Cassandrini; J Arenas; C Bruno
Journal:  Acta Myol       Date:  2007-07

8.  Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase.

Authors:  Yan Liu; Li Zeng; Keli Ma; Otto Baba; Pen Zheng; Yang Liu; Yin Wang
Journal:  Mol Neurobiol       Date:  2013-09-26       Impact factor: 5.590

Review 9.  Adeno-associated virus-mediated gene therapy for metabolic myopathy.

Authors:  Cathryn S Mah; Meghan S Soustek; A Gary Todd; Angela McCall; Barbara K Smith; Manuela Corti; Darin J Falk; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2013-11       Impact factor: 5.695

10.  Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.

Authors:  Miguel García; Anna Pujol; Albert Ruzo; Efrén Riu; Jesús Ruberte; Anna Arbós; Anna Serafín; Beatriz Albella; Juan Emilio Felíu; Fátima Bosch
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.